Lassila, Piia
Karpale, Mikko
Kummu, Outi
Stahl, Aaron
Käräjämäki, Aki
Pääkkö, Eija
Hammer, Helen Sophie
Braeuning, Albert
Pötz, Oliver
Templin, Markus
Hukkanen, Janne
Hakkola, Jukka https://orcid.org/0000-0001-5048-4363
Funding for this research was provided by:
University of Oulu
Article History
Received: 12 May 2026
Accepted: 6 August 2026
First Online: 26 August 2026
Declarations
Competing interests: The author OP declares the following competing financial interest(s): OP is shareholder of SIGNATOPE GmbH. SIGNATOPE offers assay development and service using MS-based immunoassay technology. The other authors have nothing to report.